Picture loading failed.

Pre-Made Zelminemab biosimilar, Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody: Anti-PAC1/PACAPR/PACAPRI therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-643-1mg 1mg 3090
GMP-Bios-ab-643-10mg 10mg Inquiry
GMP-Bios-ab-643-100mg 100mg Inquiry
GMP-Bios-ab-643-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Zelminemab biosimilar, Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody: Anti-PAC1/PACAPR/PACAPRI therapeutic antibody
INN Name Zelminemab
TargetPAC1R
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2019
Year Recommended2020
CompaniesAmgen
Conditions Approvedna
Conditions ActiveMigraine
Conditions Discontinuedna
Development Techna